Marbaix, S., Dauby, N., & Mould-Quevedo, J. (2023). Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population. Expert Review of Vaccines, 22(1), 608-619. https://doi.org/10.1080/14760584.2023.2229917
Chicago-referens (17:e uppl.)Marbaix, Sophie, Nicolas Dauby, och Joaquin Mould-Quevedo. "Cost-effectiveness of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly Belgian Population." Expert Review of Vaccines 22, no. 1 (2023): 608-619. https://doi.org/10.1080/14760584.2023.2229917.
MLA-referens (9:e uppl.)Marbaix, Sophie, et al. "Cost-effectiveness of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly Belgian Population." Expert Review of Vaccines, vol. 22, no. 1, 2023, pp. 608-619, https://doi.org/10.1080/14760584.2023.2229917.
